GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Bentham Science Publishers Ltd.  (7)
Material
Publisher
  • Bentham Science Publishers Ltd.  (7)
Language
Years
FID
  • 1
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2009
    In:  Current Nanoscience Vol. 5, No. 3 ( 2009-08-01), p. 293-296
    In: Current Nanoscience, Bentham Science Publishers Ltd., Vol. 5, No. 3 ( 2009-08-01), p. 293-296
    Type of Medium: Online Resource
    ISSN: 1573-4137
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2009
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2008
    In:  Current Nanoscience Vol. 4, No. 4 ( 2008-11-01), p. 397-401
    In: Current Nanoscience, Bentham Science Publishers Ltd., Vol. 4, No. 4 ( 2008-11-01), p. 397-401
    Type of Medium: Online Resource
    ISSN: 1573-4137
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2008
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2007
    In:  Current Nanoscience Vol. 3, No. 3 ( 2007-08-01), p. 259-263
    In: Current Nanoscience, Bentham Science Publishers Ltd., Vol. 3, No. 3 ( 2007-08-01), p. 259-263
    Type of Medium: Online Resource
    ISSN: 1573-4137
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2007
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2023
    In:  Current Medical Imaging Formerly Current Medical Imaging Reviews Vol. 19, No. 9 ( 2023-08)
    In: Current Medical Imaging Formerly Current Medical Imaging Reviews, Bentham Science Publishers Ltd., Vol. 19, No. 9 ( 2023-08)
    Abstract: Haglund’s syndrome is a common cause of heel pain but often neglected clinically. Haglund’s syndrome refers to a series of symptoms caused by impingement among posterosuperior prominence of the calcaneus, bursa and Achilles tendon. It is difficult to distinguish Haglund’s syndrome from other causes of heel pain by clinical diagnosis. Imageology is of great value in the diagnosis of Haglund’s syndrome. Objective: Our study aims to summarize the Magnet resonance (MR) imaging characteristics of Haglund’s syndrome and provide some reference to clinical work. Method: We retrospectively analyzed the MR images of 11 patients (6 males; 5 females; 6 right ankles, 4 left ankles, 1 bimalleolar ankles) who have been clinically and radiologically confirmed Haglund’s syndrome. Observation contents: morphological changes of calcaneus and talus, abnormal signal of calcaneus, abnormal Achilles tendon, and soft tissue abnormalities around Achilles tendon. Combined with literature reviews, summarize the MR imaging features of Haglund’s syndrome. Results: In 12 ankles, all ankles showed posterosuperior prominence of the calcaneus and Achilles tendon degeneration; 7 ankles showed bone marrow edema; 6 Achilles tendons were graded as either type II or type III tendinosis; 5 Achilles tendons showed partial tear; 12 ankles showed retrocalcaneal bursitis, 7 ankles showed retro-Achilles bursitis, 6 ankles showed Kager’s fat pad edema. Conclusion: This study found that MR images of Haglund's syndrome showed bone edema of the calcaneus, degeneration and partial tear of the Achilles tendon, the retrocalcaneal and retro-Achilles bursas, and Kager’s fat pad edema.
    Type of Medium: Online Resource
    ISSN: 1573-4056
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2023
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2023
    In:  Current Medicinal Chemistry Vol. 30, No. 24 ( 2023-07), p. 2796-2811
    In: Current Medicinal Chemistry, Bentham Science Publishers Ltd., Vol. 30, No. 24 ( 2023-07), p. 2796-2811
    Abstract: Alzheimer's disease (AD) is one of the most common diseases in the elderly, with a high incidence of dementia. The pathogenesis of AD is complex, and there is no unified conclusion and effective treatment in the clinic. In recent years, with the development of traditional Chinese medicine (TCM), researchers put forward the idea of prevention and treatment of AD based on TCM according to the characteristics of multi- target of TCM. Ferulic acid (FA), also known as 3-methoxy-4-hydroxycinnamic acid, is an active ingredient in TCM that inhibits β-amyloid (Aβ) aggregation and has antioxidant and anti-inflammatory effects. FA derivatives have been reported to have low toxicity, high biological activity, and high blood-brain barrier permeability. However, the multitarget of FA in the treatment of AD has not been systematically elucidated. Objectives: In this systematic review, we aimed to comprehensively assess the neuroprotective effects of FA and its derivatives on in vitro and in vivo AD models. Methods: We searched PubMed, Chinese National Knowledge Infrastructure (CNKI), Baidu Academic, and Wanfang databases for relevant pre-clinical studies until November 2021. Results: We identified studies that evaluated the efficacy of FA and its derivatives using relevant keywords. 864 studies were included, of which 129 were found in PubMed, 111 in CNKI, 454 in Baidu Academic, and 170 in Wanfang. Due to duplication between databases, and after applying the exclusion and inclusion criteria, 43 articles were selected. Thereafter, the abstracts of the 43 articles were reviewed. Finally, 21 articles were included in this review, including 11 in vivo, 5 in vitro, and 5 in vivo and in vitro studies. Conclusion: Previous studies have shown that FA or its derivatives have multiple therapeutic effects on AD models and can improve the symptoms of AD and resistance of AD cell models. FA and its derivatives have anti-Aβ aggregation, antioxidant, antiinflammatory, and other effects and are potential drugs for the multi-targeted treatment of AD. The result of our study showed that FA and its derivatives have significant therapeutic effects on animal and cell models of AD, suggesting that they may be potential therapeutic drugs for patients with AD.
    Type of Medium: Online Resource
    ISSN: 0929-8673
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2023
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Bentham Science Publishers Ltd. ; 2013
    In:  Current Nanoscience Vol. 9, No. 4 ( 2013-07-01), p. 451-456
    In: Current Nanoscience, Bentham Science Publishers Ltd., Vol. 9, No. 4 ( 2013-07-01), p. 451-456
    Type of Medium: Online Resource
    ISSN: 1573-4137
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2013
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Current Analytical Chemistry, Bentham Science Publishers Ltd., Vol. 20, No. 4 ( 2024-05), p. 255-263
    Abstract: Metformin is a biguanide derivative utilized as a first-line treatment for type 2 diabetes for people over 60 years. However, it faces certain limitations due to its incomplete absorption, resulting in a 50-60% bioavailability. In addition to its blood glucose-lowering effect, the antiproliferative effect of metformin has been demonstrated in vitro. Therefore, it is necessary to consider alternative administration routes that can enhance the bioavailability of metformin, expanding its clinical use beyond its role as an antidiabetic agent. Objective: The aim of the study was to develop a reliable bioanalytical method for the quantitation of metformin in male Sprague-Dawley rat plasma and explore the promising alternative administration route for metformin use. Methods: A robust, high-performance liquid chromatography-tandem mass spectrometry method for the quantification of metformin in rat plasma was developed and validated according to the latest regulatory guidance for bioanalysis. Results: Based on the area under the curves obtained from the rat pharmacokinetic study, subcutaneous injection increased the systemic exposure of metformin by 1.79-fold compared to oral administration in rats. Conclusion: Subcutaneous administration of metformin enhances its bioavailability compared to oral administration, leading to increased antidiabetic effects and potential antitumor activity.
    Type of Medium: Online Resource
    ISSN: 1573-4110
    Language: English
    Publisher: Bentham Science Publishers Ltd.
    Publication Date: 2024
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...